Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma

While surgical resection has remained the mainstay of treatment in early-stage renal cell carcinoma (RCC), therapeutic options in the advanced setting have remarkably expanded over the last 20 years. Tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor (VEGF-TKIs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardenas, Luisa M., Deluce, Jasna E., Khan, Shahrukh, Gulam, Omar, Maleki Vareki, Saman, Fernandes, Ricardo, Lalani, Aly-Khan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406353/
https://www.ncbi.nlm.nih.gov/pubmed/36005167
http://dx.doi.org/10.3390/curroncol29080429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406353/
https://www.ncbi.nlm.nih.gov/pubmed/36005167
http://dx.doi.org/10.3390/curroncol29080429

Ejemplares similares